A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA
2013 ◽
Vol 36
(8)
◽
pp. 1023-1028
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Keyword(s):
Keyword(s):